Safety assessment and probiotic characteristics of Enterococcus lactis JDM1

Microb Pathog. 2022 Feb:163:105380. doi: 10.1016/j.micpath.2021.105380. Epub 2022 Jan 1.

Abstract

Objective: The aims of this study were to evaluate the safety and probiotic characteristics of the newly isolated Enterococcus lactis strain JDM1.

Methods: Safety assessment of E. lactis JDM1 was accomplished by the combination of whole genome sequence information analysis and phenotypic assays, including antimicrobial susceptibility test, haemolysis assay, biogenic amine production assay, cytotoxicity assay. The bacteriostatic experiment and gastrointestinal tolerance experiment were also conducted to evaluate its applicability.

Results: E. lactis JDM1 possesses good gastrointestinal tolerance and can inhibit the growth of the pathogenic bacteria Clostridioides difficile and Listeria monocytogenes. The chromosome size of JDM1 was 2,570,998 bp with a GC content of 38.46%, which contained a plasmid. One intact prophage, 13 genomic islands and 19 IS elements were predicted in the JDM1 chromosome. Five resistance-related genes and seven virulence-related genes were predicted in the genome. Most resistance genes were conserved, and virulence factors were not related to functional pathogenicity. Antimicrobial susceptibility tests showed that JDM1 was sensitive to tedizolid, ciprofloxacin, levofloxacin, penicillin, ampicillin, vancomycin, linezolid, tetracycline, high-level gentamicin and high-level streptomycin. Genes encoding putative enzymes responsible for adverse metabolites were not found and JDM1 was unable to produce the six main biogenic amines. Cytotoxicity test showed that the JDM1 supernatant had no toxic effect.

Conclusion: E. lactis JDM1 is expected to be developed as a probiotic, and its probiotic properties are worthy of further exploration.

Keywords: Enterococcus lactis; Genome; Probiotics; Safety assessment.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Enterococcus* / genetics
  • Microbial Sensitivity Tests
  • Probiotics*
  • Virulence Factors / genetics

Substances

  • Anti-Bacterial Agents
  • Virulence Factors

Supplementary concepts

  • Enterococcus lactis